Products

Primary tabs

Export products to Excel

Displaying 1 - 15 of 101
Alternative Name: AF-2364
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Lead Optimization
Alternative Name: Inhibitors of Testicular Retinoic Acid Biosynthesis
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Phase III
Partner: Evofem, Inc.
Alternative Name: Suspensories
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Testicular
Project Stage: Phase II
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Alternative Name: BDADs
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Target ID/Validation
Development Status: Inactive
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Phase III
Partner: ReProtect Inc.
Alternative Name: Epididymal Calchlorin
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Phase I
Alternative Name: SILCS Diaphragm
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Alternative Name: Saheli, Ormeloxifene, Chhaya
Development Status: Limited Market Approval
Target: Female
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Marketed
Export to Excel